VUF10460 2 mg | 99.53%
TargetMol
VUF10460
Search Results
BPTU 5 mg | 99.89%
TargetMol
Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.
More Information Supplier PageBPTU
PCC0208009 1 mg | 99.89%
TargetMol
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier PagePCC0208009
PCC0208009 50 mg | 99.89%
TargetMol
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier PagePCC0208009
NSC 80538 2 mg | 99.50%
TargetMol
NSC 80538 is a chemical compound that has been studied for its potential applications in scientific research. NSC 80538 is a member of the thiourea family.
More Information Supplier PageNSC 80538
UNC0642 100 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
UNC0642 25 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
UNC0642 2 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
CY-09 25 mg | Purity Not Available
TargetMol
CY-09
CY-09 1 mg | Purity Not Available
TargetMol
CY-09